Separation and characterisation of cyclic nucleotide phosphodiesterases from the lacrimal, Harderian and zygomatic glands of the rabbit

References

• Butcher R. W., Sutherland E. W. Adenosine 3′,5′-phosphate in biological materials: I. J. Biol. Chem. 1962; 237: 1244–1250
   PubMed Web of Science ®Google Scholar
• Jahn A., Patel U., Porsch P. H., Soling H. D. Adrenocorticotropic hormone and α-melanocyte stimulating hormone induce protein phosphorylation in the rat lac-rimal gland by activation of a cAMP-dependent pathway. Eur. J. Biochem. 1982; 126: 623–629
   PubMedGoogle Scholar
• Beavo J. A., Reifsnyder D. K. Primary sequence of cyclic nucleotide phosphodiesterase isoen-zyme and the design of selective inhibitors. Trends Pharmacol. Sci. 1990; 11: 150–155
   PubMed Web of Science ®Google Scholar
• Thompson W. J. Cyclic nucleotide phosphodi-esterases: pharmacology, biochemistry and function. Pharmac. Ther. 1991; 51: 13–33
   PubMed Web of Science ®Google Scholar
• Michaeli T., Bloom T. J, Martins T., Loughney K., Ferguson K., Riggs M., Rodgers L., Beavo J. A., Wigler M. Isolation and characterisation of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase deficient saccharomyces cerevisiae. J. Biol. Chem. 1993; 268: 12925–12932
   PubMed Web of Science ®Google Scholar
• Shahid M., Nicholson C. D. Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive isotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram. Naunyn-Schmiedeberg's Arch. Pharmacol. 1990; 342: 698–705
   Google Scholar
• Nair K. G. Purification and properties of 3′,5′-cyclic nucleotide phosphodiesterase from dog heart. Biochemistry 1966; 5: 150–157
   PubMed Web of Science ®Google Scholar
• Torphy T. J., Ceisliski K. B. Characterisation and selective inhibition of cyclic nueleotide phosphodiesterase isoenzymes in canine tracheal smooth muscle. Mol. Pharmacol. 1989; 37: 206–214
   Web of Science ®Google Scholar
• Kosmas N., Lugnier C., Andriantsitohaina R., Sto-clet J.-C. Characterisation of cyclic nucleotide phosphodiesterases from rat mesenteric artery. Eur. J. Pharm. 1991; 208: 85–87
   PubMed Web of Science ®Google Scholar
• Mukai J., Asai T., Naka M., Tanaka T. Separation and characterisation of a novel isoenzyme of cyclic nucleotide phosphodiesterase from rat cerebrum. Br. J. Pharmacol. 1994; 111: 389–390
   PubMed Web of Science ®Google Scholar
• Thompson W. J., Appleman M. M. Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 1970; 10: 311–316
   Web of Science ®Google Scholar
• Millar T. J., Herok G., Koutavas H., Martin D. K., Anderton P. J. Immunohistochemical characterisation of epithelial cells of rabbit lacrimal glands in tissue sections and cell cultures. Tissue and Cell 1996, In Press
   PubMed Web of Science ®Google Scholar
• Spoto G., Whitehead E., Ferraro A., Di Terrlizzi P., Turano C., Riva F. A reverse-phase HPLC method for cAMP phosphodiesterase activity. Anal. Bio-chem. 1991; 196: 207–210
   Google Scholar
• Methven P., Lemon M., Bhoola K. The metabolism of cyclic nucleotides in the guinea-pig pancreas. Biochem. J. 1980; 186: 491–494
   PubMedGoogle Scholar
• Beavo J. A, Hansen R. S, Harrison R. L, Hurwitz R. L, Martins T. J., Mumby M. C. Identification and properties of cyclic nucleotide phosphodiesterase. Mol. Cell. Endoc. 1982; 28: 387–410
   PubMed Web of Science ®Google Scholar
• Huhtala A., Huikuri K. T, Palkama A., Tervo T. Innervation of the rat Harderian gland by adrener-gic and cholinergic nerve fibres. Anat. Rec. 1977; 188: 263–271
   PubMedGoogle Scholar
• Al-Gailani M., Asking B., Emtnelin N., Garrett J. R. Functional and structural studies concerning the control of activity in zygomatic glands of cats. J. Autonom. Nerv. Sys. 1981; 3: 71–76
   PubMedGoogle Scholar
• Wells J. N, Baird C. E, Wu Y. J., Hardman J. G. Cyclic nucleotide phosphodiesterase activities of pig coronary arteries. Biochim. Biophys. Acta 1975; 384: 430–442
   PubMedGoogle Scholar
• Reeves M., Leigh B. K., England P. J. The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Biochem. J. 1987; 241: 535–554
   PubMed Web of Science ®Google Scholar
• Torphy T. J, Undem B. J, Cieslinski L. B, Luttmann M. A, Reeves M. L., Hay D. W. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J. Pharmacol. Exp. Ther. 1993; 265: 1213–1223
   PubMed Web of Science ®Google Scholar
• Shahid M., van Amersterdam R. G. M., de Boer J., ten Berge R. E, Nicholson C. D., Zaagsma J. The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors. Br. J. Pharmacol. 1991; 104: 471–477
   PubMed Web of Science ®Google Scholar
• Truss M. C, Uckert S., Stief C. G, Schulz-Knappe P., Hess R., Forssmann W.-G., Jonas U. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterisation and functional effects of various phosphodiesterase inhibitors in vitro. Urology 1994; 45: 893–901
   Web of Science ®Google Scholar
• Saeki T., Saito I. Isolation of cyclic nucleotide phosphodiesterase isozymes from pig aorta. Biochem. Pharmacol. 1993; 46: 833–839
   PubMed Web of Science ®Google Scholar
• Weishaar R. E, Burrows S. D, Kobylarz D. C, Quade M. M., Evans D. B. Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Biochem. Pharmac. 1985; 35: 787–800
   Web of Science ®Google Scholar
• Hoey M., Houslay M. D. Identification and selective inhibition of four distinct soluble forms of cyclic nucleotide phosphodiesterase activity from kidney. Biochem. Pharm. 1990; 40: 193–202
   PubMed Web of Science ®Google Scholar
• Lee K. C, Silver P. J, Bode D. C., Gherezghiher T. Ocular effects of topical administration of the phosphodiesterase III inhibitor milrinone in rabbits and cats. Meth. Find. Exp. Clin. Pharmacol. 1993; 15: 527–534
   PubMed Web of Science ®Google Scholar
• Gilbard J. P, Rossi S. R, Heyda K. G., Dartt D. A. Stimulation of tear secretion and treatment of dry-eye disease with 3-isobutyl-1-methylxanthine. Arch. Oph-thalmol. 1991; 109: 672–676
   PubMedGoogle Scholar